Immune response of peripheral blood mononuclear cells to HBx‐antigen of hepatitis B virus

The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg. We have investigated whether this antigen is a target structure for human T‐lymphocytes. Using recombinant HBxAg protein, we found HBxAg‐specific stimulation of peripheral blood mononuclear cells in patients with acute hepatitis B virus infection (6 of 6) and chronic hepatitis B virus infection (6 of 17) but not in healthy individuals. With HBxAg‐specific synthetic polypeptides, several T‐cell epitopes were identified. Most were located in the carboxyterminal half of the HBxAg protein. Five T‐cell clones specific for a T‐cell epitope located at the carboxyterminal region of HBxAg were established and found to belong to the CD2/CD4‐positive, CD8‐negative subtype. These data establish for the first time HBxAg as an antigen in the cellular immune response. (HEPATOLOGY 1991;13:63–643.)

[1]  M. Levrero,et al.  Mapping of B-cell epitopes of the human hepatitis B virus X protein , 1990, Journal of virology.

[2]  D. Ganem,et al.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication , 1989, Journal of virology.

[3]  W. Robinson,et al.  Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Yoshioka,et al.  Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. , 1989, Journal of immunology.

[5]  P. Hofschneider,et al.  A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. , 1988, Oncogene.

[6]  B. Peterlin,et al.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Hess,et al.  Serological evidence for expression of the polymerase gene of human hepatitis B virus in vivo. , 1988, The Journal of general virology.

[8]  D. Spandau,et al.  trans-activation of viral enhancers by the hepatitis B virus X protein , 1988, Journal of virology.

[9]  G. Duncan,et al.  Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections , 1988, Journal of medical virology.

[10]  C. Ferrari,et al.  Cellular immune response to hepatitis B virus antigens. An overview. , 1988, Journal of hepatology.

[11]  J. Twu,et al.  Transcriptional trans-activating function of hepatitis B virus , 1987, Journal of virology.

[12]  U. Koszinowski,et al.  CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity , 1987, Journal of virology.

[13]  F. Chisari,et al.  Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. , 1987, Journal of immunology.

[14]  F. Chisari,et al.  Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. , 1987, Journal of immunology.

[15]  A. Alberti,et al.  Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. , 1987, Clinical and experimental immunology.

[16]  H. Varmus,et al.  Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus , 1986, Journal of virology.

[17]  C. Debouck,et al.  Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Miyaki,et al.  Integration of region X of hepatitis B virus genome in human primary hepatocellular carcinomas propagated in nude mice. , 1986, The Journal of general virology.

[19]  E. Rieber,et al.  Direct monoclonal antibody rosetting. An effective method for weak antigen detection and large scale separation of human mononuclear cells. , 1986, Journal of immunological methods.

[20]  M. Feitelson Products of the “x” gene in hepatitis B and related viruses , 1986, Hepatology.

[21]  G. Riethmüller,et al.  Cytolytic T cell clones derived from liver tissue of patients with chronic hepatitis B , 1986, European journal of immunology.

[22]  S. Thung,et al.  Molecular and cellular pathology of hepatitis B. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[23]  F. Galibert,et al.  The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. , 1985, The EMBO journal.

[24]  H. Will,et al.  Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Lerner,et al.  Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. , 1985, Science.

[26]  J. Vilček,et al.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Chang,et al.  Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis. , 1984, Journal of Immunology.

[28]  D. Vergani,et al.  Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. , 1982, Journal of immunology.

[29]  W. Fiers,et al.  Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda. , 1981, Gene.

[30]  Walter Gilbert,et al.  Hepatitis B virus genes and their expression in E. coli , 1979, Nature.

[31]  F. Galibert,et al.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli , 1979, Nature.

[32]  S. Sherlock,et al.  Cellular immunity and hepatitis-associated, Australia antigen liver disease. , 1972, Lancet.

[33]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.